Gene Symbol | Gene ID | Gene Info |
---|---|---|
Hoxa4
|
ENSMUSG00000000942.10 | homeobox A4 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr6_52188838_52189078 | Hoxa4 | 2795 | 0.074336 | -0.48 | 2.0e-04 | Click! |
chr6_52189500_52189651 | Hoxa4 | 2178 | 0.090565 | -0.43 | 1.1e-03 | Click! |
chr6_52189208_52189406 | Hoxa4 | 2446 | 0.082122 | -0.40 | 2.3e-03 | Click! |
chr6_52191848_52192469 | Hoxa4 | 405 | 0.563329 | -0.35 | 8.8e-03 | Click! |
chr6_52194960_52195111 | Hoxa4 | 3282 | 0.067503 | -0.32 | 1.6e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr1_84086467_84086780 | 21.85 |
Pid1 |
phosphotyrosine interaction domain containing 1 |
33370 |
0.18 |
chrX_10010308_10010474 | 20.62 |
Gm5754 |
predicted gene 5754 |
1397 |
0.54 |
chr1_41605098_41605443 | 19.42 |
Gm28634 |
predicted gene 28634 |
75727 |
0.12 |
chr14_93451377_93451568 | 19.18 |
Gm48964 |
predicted gene, 48964 |
140335 |
0.05 |
chr4_71230496_71230834 | 18.90 |
Gm11229 |
predicted gene 11229 |
55277 |
0.16 |
chr5_106577367_106577576 | 18.47 |
Gm29464 |
predicted gene 29464 |
2596 |
0.19 |
chr2_63669718_63669895 | 16.70 |
Gm23503 |
predicted gene, 23503 |
237612 |
0.02 |
chr7_31127074_31128340 | 16.38 |
Scn1b |
sodium channel, voltage-gated, type I, beta |
704 |
0.47 |
chrX_22849990_22850177 | 16.20 |
Gm26131 |
predicted gene, 26131 |
11853 |
0.32 |
chrX_22849813_22849966 | 14.50 |
Gm26131 |
predicted gene, 26131 |
12047 |
0.31 |
chr2_17839635_17839891 | 14.29 |
Gm13323 |
predicted gene 13323 |
41779 |
0.17 |
chr8_54975613_54975775 | 14.20 |
Gm45263 |
predicted gene 45263 |
15875 |
0.14 |
chr13_36283759_36283936 | 14.01 |
Gm48766 |
predicted gene, 48766 |
31488 |
0.17 |
chr14_14350947_14351733 | 13.68 |
Il3ra |
interleukin 3 receptor, alpha chain |
1719 |
0.23 |
chr13_47505724_47505875 | 13.67 |
Gm35733 |
predicted gene, 35733 |
144413 |
0.04 |
chr7_93061692_93062023 | 13.22 |
Fam181b |
family with sequence similarity 181, member B |
18008 |
0.16 |
chr7_67468944_67469359 | 13.20 |
Gm33926 |
predicted gene, 33926 |
25218 |
0.17 |
chr4_5962411_5962640 | 12.96 |
Gm11796 |
predicted gene 11796 |
107038 |
0.07 |
chr3_17619540_17619872 | 12.82 |
Gm38154 |
predicted gene, 38154 |
50982 |
0.17 |
chr16_77236770_77236921 | 12.72 |
Mir99ahg |
Mir99a and Mirlet7c-1 host gene (non-protein coding) |
526 |
0.83 |
chr18_47647195_47647522 | 12.45 |
Gm5236 |
predicted gene 5236 |
82409 |
0.08 |
chr10_108133791_108134149 | 12.34 |
Gm47999 |
predicted gene, 47999 |
8462 |
0.25 |
chr5_26991582_26992107 | 12.15 |
Gm16057 |
predicted gene 16057 |
15777 |
0.25 |
chr6_77979020_77979189 | 12.10 |
Ctnna2 |
catenin (cadherin associated protein), alpha 2 |
446 |
0.85 |
chr7_70103761_70103947 | 12.06 |
Gm35325 |
predicted gene, 35325 |
103581 |
0.06 |
chr13_83744885_83745867 | 12.00 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
6513 |
0.13 |
chr2_56454778_56454958 | 11.92 |
Mir195b |
microRNA 195b |
330943 |
0.01 |
chr3_115856880_115857079 | 11.83 |
Dph5 |
diphthamide biosynthesis 5 |
30858 |
0.11 |
chr1_119049949_119050658 | 11.67 |
Gli2 |
GLI-Kruppel family member GLI2 |
3036 |
0.28 |
chr3_144411063_144411292 | 11.51 |
Gm5857 |
predicted gene 5857 |
16495 |
0.21 |
chr14_62455363_62455547 | 11.51 |
Gucy1b2 |
guanylate cyclase 1, soluble, beta 2 |
662 |
0.68 |
chr1_81593953_81594167 | 11.38 |
Gm6198 |
predicted gene 6198 |
36577 |
0.2 |
chr19_15803560_15803774 | 11.38 |
Gm50348 |
predicted gene, 50348 |
609 |
0.82 |
chr1_104619903_104620054 | 11.32 |
Gm29592 |
predicted gene 29592 |
10454 |
0.22 |
chr4_24429638_24429836 | 11.31 |
Gm27243 |
predicted gene 27243 |
1153 |
0.54 |
chr10_87489779_87490093 | 11.24 |
Ascl1 |
achaete-scute family bHLH transcription factor 1 |
3724 |
0.24 |
chr18_40459021_40459343 | 11.21 |
Gm31019 |
predicted gene, 31019 |
19445 |
0.22 |
chr4_91230669_91230848 | 11.17 |
Elavl2 |
ELAV like RNA binding protein 1 |
23824 |
0.23 |
chr4_16357861_16358012 | 11.15 |
Gm37355 |
predicted gene, 37355 |
26116 |
0.19 |
chr3_110010804_110011296 | 11.11 |
Gm12535 |
predicted gene 12535 |
103666 |
0.07 |
chr5_131794610_131795069 | 11.07 |
4930563F08Rik |
RIKEN cDNA 4930563F08 gene |
85430 |
0.06 |
chr12_10874948_10875116 | 10.98 |
Pgk1-rs7 |
phosphoglycerate kinase-1, related sequence-7 |
25208 |
0.23 |
chr4_53253649_53254014 | 10.93 |
4930522O17Rik |
RIKEN cDNA 4930522O17 gene |
7635 |
0.18 |
chr14_16200927_16201541 | 10.90 |
Rpl31-ps3 |
ribosomal protein L31, pseudogene 3 |
23789 |
0.13 |
chr1_138497460_138497658 | 10.86 |
Gm28501 |
predicted gene 28501 |
18056 |
0.2 |
chr4_28143160_28143344 | 10.85 |
Gm11911 |
predicted gene 11911 |
76075 |
0.11 |
chr2_51087621_51088075 | 10.85 |
Rnd3 |
Rho family GTPase 3 |
61246 |
0.13 |
chr9_41578468_41578685 | 10.78 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
918 |
0.39 |
chr4_56128107_56128471 | 10.76 |
Gm12520 |
predicted gene 12520 |
34651 |
0.21 |
chr6_6871537_6871723 | 10.74 |
Dlx6os1 |
distal-less homeobox 6, opposite strand 1 |
38 |
0.96 |
chr18_81251894_81252538 | 10.61 |
Gm30192 |
predicted gene, 30192 |
12475 |
0.22 |
chr18_45123111_45123296 | 10.48 |
Gm4839 |
predicted gene 4839 |
23923 |
0.15 |
chr15_18190602_18190753 | 10.47 |
Gm8318 |
predicted gene 8318 |
26796 |
0.22 |
chr6_22794374_22794759 | 10.46 |
Gm25942 |
predicted gene, 25942 |
4748 |
0.17 |
chr15_95217343_95217494 | 10.32 |
1700129L04Rik |
RIKEN cDNA 1700129L04 gene |
55024 |
0.17 |
chr4_71229701_71230138 | 10.31 |
Gm11229 |
predicted gene 11229 |
56023 |
0.15 |
chr16_43800088_43800449 | 10.29 |
Gm25996 |
predicted gene, 25996 |
2851 |
0.23 |
chr10_38553365_38553786 | 10.28 |
Gm22911 |
predicted gene, 22911 |
61906 |
0.14 |
chr10_21082754_21082905 | 10.20 |
Ahi1 |
Abelson helper integration site 1 |
12984 |
0.14 |
chr12_92589210_92589401 | 10.20 |
Gm18500 |
predicted gene, 18500 |
115344 |
0.07 |
chr5_88583730_88583896 | 10.17 |
Rufy3 |
RUN and FYVE domain containing 3 |
19 |
0.97 |
chr1_165935347_165935547 | 10.13 |
Pou2f1 |
POU domain, class 2, transcription factor 1 |
436 |
0.79 |
chr4_5724163_5724370 | 10.12 |
Fam110b |
family with sequence similarity 110, member B |
46 |
0.98 |
chr11_80623114_80623380 | 10.11 |
C030013C21Rik |
RIKEN cDNA C030013C21 gene |
114141 |
0.05 |
chr13_99284457_99284785 | 10.05 |
Ptcd2 |
pentatricopeptide repeat domain 2 |
60084 |
0.11 |
chrX_143933301_143933468 | 10.04 |
Dcx |
doublecortin |
73 |
0.98 |
chr5_83593274_83593496 | 10.04 |
Gm25765 |
predicted gene, 25765 |
55569 |
0.15 |
chr10_46827443_46827788 | 10.01 |
Gm25650 |
predicted gene, 25650 |
10892 |
0.24 |
chr15_18818116_18818289 | 9.98 |
C030047K22Rik |
RIKEN cDNA C030047K22 gene |
572 |
0.56 |
chr3_115950011_115950162 | 9.98 |
Gm6649 |
predicted gene 6649 |
6989 |
0.11 |
chr3_98990771_98991097 | 9.94 |
5730437C11Rik |
RIKEN cDNA 5730437C11 gene |
49678 |
0.1 |
chr14_102205486_102205672 | 9.93 |
Gm22347 |
predicted gene, 22347 |
124082 |
0.06 |
chr2_21009863_21010014 | 9.91 |
Gm13375 |
predicted gene 13375 |
40884 |
0.14 |
chr8_45558513_45558673 | 9.84 |
Gm45458 |
predicted gene 45458 |
18478 |
0.16 |
chr14_84547621_84547783 | 9.84 |
9630013A20Rik |
RIKEN cDNA 9630013A20 gene |
71278 |
0.12 |
chr4_41612407_41612596 | 9.73 |
Dnaic1 |
dynein, axonemal, intermediate chain 1 |
19143 |
0.1 |
chr16_64332936_64333087 | 9.72 |
Csnka2ip |
casein kinase 2, alpha prime interacting protein |
146137 |
0.05 |
chr18_74956688_74957137 | 9.71 |
Lipg |
lipase, endothelial |
4350 |
0.11 |
chr9_110053315_110053992 | 9.69 |
Map4 |
microtubule-associated protein 4 |
1601 |
0.28 |
chr15_4378780_4379184 | 9.65 |
Plcxd3 |
phosphatidylinositol-specific phospholipase C, X domain containing 3 |
3478 |
0.36 |
chr6_28370428_28370579 | 9.64 |
Gm5303 |
predicted gene 5303 |
7338 |
0.16 |
chr3_50421873_50422272 | 9.62 |
Gm37498 |
predicted gene, 37498 |
17789 |
0.21 |
chr9_58049078_58049250 | 9.52 |
Ccdc33 |
coiled-coil domain containing 33 |
7128 |
0.13 |
chr10_56059015_56059173 | 9.46 |
Gm29794 |
predicted gene, 29794 |
42909 |
0.17 |
chr18_59860219_59860960 | 9.43 |
Gm38695 |
predicted gene, 38695 |
5127 |
0.21 |
chr9_122593300_122593525 | 9.40 |
9530059O14Rik |
RIKEN cDNA 9530059O14 gene |
20910 |
0.13 |
chr19_59044212_59044389 | 9.39 |
Shtn1 |
shootin 1 |
6015 |
0.22 |
chr15_70594450_70594601 | 9.38 |
Gm18155 |
predicted gene, 18155 |
163528 |
0.04 |
chrX_93409170_93409369 | 9.35 |
Pola1 |
polymerase (DNA directed), alpha 1 |
81677 |
0.09 |
chr3_69709128_69709981 | 9.33 |
Rpl32-ps |
ribosomal protein L32, pseudogene |
7839 |
0.17 |
chr13_90643930_90644265 | 9.27 |
Gm36966 |
predicted gene, 36966 |
10012 |
0.25 |
chr2_144128059_144128224 | 9.24 |
Gm11687 |
predicted gene 11687 |
15232 |
0.16 |
chr19_28380893_28381046 | 9.22 |
Glis3 |
GLIS family zinc finger 3 |
54963 |
0.16 |
chr6_16316868_16317055 | 9.21 |
Gm3148 |
predicted gene 3148 |
79334 |
0.1 |
chr3_88205532_88206477 | 9.20 |
Gm3764 |
predicted gene 3764 |
809 |
0.34 |
chr1_159615199_159615416 | 9.19 |
Gm10530 |
predicted gene 10530 |
558 |
0.8 |
chr8_14381805_14382050 | 9.16 |
Dlgap2 |
DLG associated protein 2 |
21 |
0.98 |
chr4_11762140_11762451 | 9.15 |
Cdh17 |
cadherin 17 |
4102 |
0.26 |
chr2_114341126_114341277 | 9.11 |
Gm29234 |
predicted gene 29234 |
67766 |
0.12 |
chr14_123064863_123065073 | 9.09 |
AA536875 |
expressed sequence AA536875 |
21686 |
0.22 |
chrX_47124585_47124785 | 9.07 |
Gm14609 |
predicted gene 14609 |
256649 |
0.02 |
chr5_85240015_85240217 | 9.05 |
Gm21006 |
predicted gene, 21006 |
373271 |
0.01 |
chr4_13480505_13480805 | 9.05 |
Gm11826 |
predicted gene 11826 |
2537 |
0.36 |
chr2_63669900_63670081 | 9.03 |
Gm23503 |
predicted gene, 23503 |
237796 |
0.02 |
chr13_52562127_52562509 | 9.03 |
Syk |
spleen tyrosine kinase |
20855 |
0.22 |
chr13_109053247_109053648 | 8.99 |
Pde4d |
phosphodiesterase 4D, cAMP specific |
62789 |
0.16 |
chr11_25696299_25696505 | 8.97 |
Gm23514 |
predicted gene, 23514 |
11262 |
0.27 |
chr1_55489399_55489736 | 8.95 |
Gm6644 |
predicted gene 6644 |
44543 |
0.12 |
chr3_40673604_40673797 | 8.93 |
Intu |
inturned planar cell polarity protein |
1079 |
0.49 |
chr1_158547905_158548203 | 8.91 |
Gm37848 |
predicted gene, 37848 |
3912 |
0.17 |
chr17_49044163_49044341 | 8.84 |
Gm44304 |
predicted gene, 44304 |
52181 |
0.14 |
chr10_36567405_36567569 | 8.84 |
Gm47054 |
predicted gene, 47054 |
46587 |
0.17 |
chr6_78245260_78245429 | 8.82 |
Gm5576 |
predicted pseudogene 5576 |
29466 |
0.21 |
chr1_63763173_63763740 | 8.82 |
4933402D24Rik |
RIKEN cDNA 4933402D24 gene |
5811 |
0.18 |
chr1_30009154_30009305 | 8.80 |
Gm23771 |
predicted gene, 23771 |
23295 |
0.25 |
chr1_42539688_42540042 | 8.79 |
Gm37047 |
predicted gene, 37047 |
48052 |
0.15 |
chr4_23843717_23843902 | 8.78 |
Gm28448 |
predicted gene 28448 |
90145 |
0.1 |
chr3_34838105_34838267 | 8.77 |
Gm21388 |
predicted gene, 21388 |
1036 |
0.6 |
chr2_85198006_85198625 | 8.76 |
Lrrc55 |
leucine rich repeat containing 55 |
1118 |
0.31 |
chr12_95119304_95119472 | 8.72 |
Gm4808 |
predicted gene 4808 |
203706 |
0.03 |
chr16_73108327_73108499 | 8.71 |
4930500H12Rik |
RIKEN cDNA 4930500H12 gene |
9425 |
0.31 |
chr3_103945068_103945253 | 8.68 |
Rsbn1 |
rosbin, round spermatid basic protein 1 |
16542 |
0.1 |
chr11_36696899_36697978 | 8.68 |
Tenm2 |
teneurin transmembrane protein 2 |
19693 |
0.24 |
chr7_69579254_69579507 | 8.66 |
Gm44535 |
predicted gene 44535 |
328 |
0.9 |
chr2_106513126_106513315 | 8.65 |
Gm14015 |
predicted gene 14015 |
9883 |
0.26 |
chr1_132591364_132591989 | 8.63 |
Nfasc |
neurofascin |
4536 |
0.23 |
chr2_79048001_79048199 | 8.62 |
Gm14469 |
predicted gene 14469 |
9366 |
0.22 |
chr11_12742451_12742668 | 8.61 |
Gm22789 |
predicted gene, 22789 |
49746 |
0.17 |
chr13_34095941_34096108 | 8.60 |
Gm47065 |
predicted gene, 47065 |
6997 |
0.11 |
chr12_78001910_78002237 | 8.60 |
Gm24994 |
predicted gene, 24994 |
163473 |
0.03 |
chr16_42275501_42275854 | 8.59 |
Gap43 |
growth associated protein 43 |
395 |
0.88 |
chr16_49408354_49408582 | 8.58 |
Gm4802 |
predicted gene 4802 |
4162 |
0.24 |
chr13_84063075_84063226 | 8.57 |
Gm17750 |
predicted gene, 17750 |
1622 |
0.43 |
chr19_14518544_14518881 | 8.56 |
Tle4 |
transducin-like enhancer of split 4 |
76827 |
0.11 |
chr16_91173819_91174057 | 8.56 |
Gm49613 |
predicted gene, 49613 |
1396 |
0.29 |
chr14_93083221_93083444 | 8.55 |
Gm23509 |
predicted gene, 23509 |
54857 |
0.15 |
chr6_6869149_6869300 | 8.55 |
Dlx6os1 |
distal-less homeobox 6, opposite strand 1 |
2368 |
0.19 |
chr12_52138386_52138571 | 8.54 |
Nubpl |
nucleotide binding protein-like |
6094 |
0.26 |
chr6_106916863_106917143 | 8.53 |
Gm22418 |
predicted gene, 22418 |
84449 |
0.09 |
chr19_41164805_41164972 | 8.53 |
Tll2 |
tolloid-like 2 |
41886 |
0.16 |
chr14_123513080_123513404 | 8.52 |
Nalcn |
sodium leak channel, non-selective |
113634 |
0.06 |
chr3_117826650_117826801 | 8.50 |
Snx7 |
sorting nexin 7 |
4549 |
0.26 |
chr10_64089762_64089913 | 8.49 |
Lrrtm3 |
leucine rich repeat transmembrane neuronal 3 |
410 |
0.92 |
chr1_63828562_63828745 | 8.47 |
Gm13751 |
predicted gene 13751 |
16925 |
0.19 |
chr19_59006883_59007106 | 8.46 |
Shtn1 |
shootin 1 |
31291 |
0.15 |
chr11_32157683_32158170 | 8.44 |
Gm12109 |
predicted gene 12109 |
27079 |
0.12 |
chr11_88585408_88585611 | 8.44 |
Msi2 |
musashi RNA-binding protein 2 |
4638 |
0.29 |
chrX_105391243_105391597 | 8.44 |
5330434G04Rik |
RIKEN cDNA 5330434G04 gene |
334 |
0.87 |
chr10_13107920_13108404 | 8.41 |
Plagl1 |
pleiomorphic adenoma gene-like 1 |
5303 |
0.23 |
chr3_50634552_50634703 | 8.41 |
Gm37199 |
predicted gene, 37199 |
6216 |
0.19 |
chr13_28811226_28811377 | 8.40 |
Gm17528 |
predicted gene, 17528 |
15822 |
0.19 |
chr15_74162477_74162748 | 8.40 |
Gm15387 |
predicted gene 15387 |
68279 |
0.11 |
chr3_10892120_10892293 | 8.40 |
Gm22795 |
predicted gene, 22795 |
83380 |
0.09 |
chr11_36054553_36054713 | 8.40 |
Gm12126 |
predicted gene 12126 |
26031 |
0.21 |
chr8_59353078_59353229 | 8.38 |
Gm34370 |
predicted gene, 34370 |
66153 |
0.14 |
chr3_34663787_34664021 | 8.35 |
Gm42693 |
predicted gene 42693 |
385 |
0.72 |
chr9_106126758_106127335 | 8.35 |
Gm29208 |
predicted gene 29208 |
8 |
0.95 |
chr8_90741434_90741741 | 8.33 |
Gm35850 |
predicted gene, 35850 |
812 |
0.58 |
chrX_93300120_93300496 | 8.32 |
Arx |
aristaless related homeobox |
13798 |
0.23 |
chr3_115774445_115774621 | 8.31 |
Gm9889 |
predicted gene 9889 |
59383 |
0.1 |
chr12_59461635_59461822 | 8.30 |
Gm48268 |
predicted gene, 48268 |
106119 |
0.06 |
chr11_71440110_71440341 | 8.28 |
Gm16013 |
predicted gene 16013 |
4045 |
0.27 |
chr13_78581429_78581797 | 8.27 |
Gm48402 |
predicted gene, 48402 |
56404 |
0.14 |
chr12_29527021_29527799 | 8.26 |
Myt1l |
myelin transcription factor 1-like |
974 |
0.61 |
chr2_37908628_37908779 | 8.25 |
Dennd1a |
DENN/MADD domain containing 1A |
56263 |
0.13 |
chr10_38554173_38554374 | 8.25 |
Gm22911 |
predicted gene, 22911 |
61208 |
0.14 |
chr4_23832115_23832327 | 8.24 |
Gm28448 |
predicted gene 28448 |
101733 |
0.08 |
chr5_39052935_39053150 | 8.24 |
Gm42857 |
predicted gene 42857 |
50011 |
0.17 |
chr2_178326923_178327667 | 8.23 |
Phactr3 |
phosphatase and actin regulator 3 |
261 |
0.94 |
chr10_39409622_39409773 | 8.22 |
Fyn |
Fyn proto-oncogene |
10312 |
0.2 |
chr5_25652525_25652696 | 8.21 |
Gm43972 |
predicted gene, 43972 |
7199 |
0.15 |
chr3_79417407_79417581 | 8.21 |
Fnip2 |
folliculin interacting protein 2 |
48711 |
0.13 |
chr17_56693837_56694281 | 8.20 |
Ranbp3 |
RAN binding protein 3 |
2676 |
0.16 |
chr3_4797268_4797439 | 8.18 |
1110015O18Rik |
RIKEN cDNA 1110015O18 gene |
205 |
0.96 |
chr14_68196691_68197044 | 8.18 |
Gm47212 |
predicted gene, 47212 |
21386 |
0.18 |
chr1_12410598_12410778 | 8.18 |
Mir6341 |
microRNA 6341 |
15298 |
0.24 |
chr3_20986036_20986280 | 8.17 |
Gm7488 |
predicted gene 7488 |
63407 |
0.13 |
chr3_38568239_38568443 | 8.16 |
Gm7824 |
predicted gene 7824 |
9673 |
0.18 |
chr6_144419162_144419621 | 8.16 |
Sox5os2 |
SRY (sex determining region Y)-box 5, opposite strand 2 |
61834 |
0.15 |
chr3_55873315_55873490 | 8.15 |
Gm43376 |
predicted gene 43376 |
16904 |
0.19 |
chr9_61102640_61102823 | 8.15 |
4933433G08Rik |
RIKEN cDNA 4933433G08 gene |
2654 |
0.21 |
chr15_103519019_103519226 | 8.15 |
Pde1b |
phosphodiesterase 1B, Ca2+-calmodulin dependent |
4202 |
0.16 |
chr10_21882678_21882893 | 8.14 |
Sgk1 |
serum/glucocorticoid regulated kinase 1 |
416 |
0.83 |
chr4_8098087_8098399 | 8.14 |
Gm11800 |
predicted gene 11800 |
20377 |
0.24 |
chr18_66023470_66023684 | 8.11 |
Lman1 |
lectin, mannose-binding, 1 |
997 |
0.47 |
chr13_84059669_84060031 | 8.07 |
Gm17750 |
predicted gene, 17750 |
4922 |
0.24 |
chr3_87973849_87975045 | 8.05 |
Nes |
nestin |
3318 |
0.12 |
chr16_72028231_72028382 | 8.05 |
Gm49667 |
predicted gene, 49667 |
149262 |
0.04 |
chr8_45508324_45508475 | 8.05 |
Sorbs2 |
sorbin and SH3 domain containing 2 |
481 |
0.81 |
chr6_77862875_77863026 | 8.04 |
Gm44437 |
predicted gene, 44437 |
113168 |
0.06 |
chr16_63278367_63278696 | 8.01 |
Gm33912 |
predicted gene, 33912 |
61089 |
0.15 |
chrX_93301651_93301845 | 8.00 |
Arx |
aristaless related homeobox |
15238 |
0.23 |
chr12_89699466_89699833 | 7.99 |
Gm48692 |
predicted gene, 48692 |
43926 |
0.2 |
chr18_43391153_43391304 | 7.99 |
Dpysl3 |
dihydropyrimidinase-like 3 |
2149 |
0.36 |
chr10_56892903_56893581 | 7.98 |
Gm48053 |
predicted gene, 48053 |
21523 |
0.23 |
chr14_115406601_115406770 | 7.98 |
4930505G20Rik |
RIKEN cDNA 4930505G20 gene |
2867 |
0.4 |
chr4_6979991_6980165 | 7.97 |
Tox |
thymocyte selection-associated high mobility group box |
10405 |
0.28 |
chr3_10685679_10685948 | 7.96 |
Gm37831 |
predicted gene, 37831 |
39497 |
0.17 |
chr13_21897327_21897714 | 7.96 |
Mir1983 |
microRNA 1983 |
471 |
0.57 |
chr1_161380092_161380398 | 7.96 |
Tnfsf4 |
tumor necrosis factor (ligand) superfamily, member 4 |
15164 |
0.21 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.2 | 15.5 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
2.7 | 13.5 | GO:0030910 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
2.6 | 7.7 | GO:0046684 | response to pyrethroid(GO:0046684) |
2.6 | 18.0 | GO:0016198 | axon choice point recognition(GO:0016198) |
2.6 | 7.7 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
2.3 | 4.5 | GO:0048880 | sensory system development(GO:0048880) |
2.2 | 6.6 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
2.2 | 13.1 | GO:0098596 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
2.2 | 6.5 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
2.0 | 5.9 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
1.9 | 7.8 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
1.9 | 5.8 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
1.9 | 7.6 | GO:0021780 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
1.9 | 15.2 | GO:0021860 | pyramidal neuron development(GO:0021860) |
1.8 | 5.3 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
1.7 | 5.1 | GO:0021776 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
1.7 | 11.7 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
1.7 | 5.0 | GO:0002877 | regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) |
1.6 | 4.9 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
1.6 | 4.8 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
1.4 | 5.5 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
1.4 | 5.4 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
1.4 | 5.4 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
1.3 | 4.0 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
1.3 | 3.9 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
1.3 | 3.9 | GO:0090296 | regulation of mitochondrial DNA replication(GO:0090296) |
1.3 | 3.8 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
1.3 | 1.3 | GO:0050883 | musculoskeletal movement, spinal reflex action(GO:0050883) |
1.3 | 3.8 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
1.3 | 9.0 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
1.2 | 7.2 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
1.2 | 7.1 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
1.2 | 6.9 | GO:0035989 | tendon development(GO:0035989) |
1.1 | 4.6 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
1.1 | 3.4 | GO:0035262 | gonad morphogenesis(GO:0035262) |
1.1 | 2.2 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
1.1 | 3.3 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
1.1 | 3.3 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
1.1 | 3.2 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
1.1 | 2.1 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
1.1 | 8.5 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
1.1 | 3.2 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
1.0 | 8.3 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
1.0 | 7.2 | GO:1903147 | negative regulation of mitophagy(GO:1903147) |
1.0 | 3.0 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
1.0 | 5.9 | GO:0021960 | anterior commissure morphogenesis(GO:0021960) |
0.9 | 7.5 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
0.9 | 3.8 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.9 | 2.8 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.9 | 1.8 | GO:0072338 | creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
0.9 | 2.7 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.9 | 3.5 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.9 | 3.5 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
0.9 | 4.3 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.9 | 2.6 | GO:0003284 | septum primum development(GO:0003284) atrial septum primum morphogenesis(GO:0003289) |
0.9 | 2.6 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.8 | 2.5 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.8 | 4.1 | GO:0019532 | oxalate transport(GO:0019532) |
0.8 | 2.4 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.8 | 4.0 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.8 | 3.2 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.8 | 3.1 | GO:0003139 | secondary heart field specification(GO:0003139) |
0.8 | 1.5 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.8 | 2.3 | GO:0061156 | pulmonary artery morphogenesis(GO:0061156) |
0.8 | 3.0 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.8 | 1.5 | GO:0060166 | olfactory pit development(GO:0060166) |
0.7 | 2.2 | GO:1904861 | excitatory synapse assembly(GO:1904861) |
0.7 | 5.9 | GO:0048664 | neuron fate determination(GO:0048664) |
0.7 | 2.2 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.7 | 2.9 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
0.7 | 9.4 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.7 | 1.4 | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction(GO:0086064) |
0.7 | 7.8 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.7 | 1.4 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.7 | 2.8 | GO:1903818 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.7 | 2.1 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.7 | 2.7 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.7 | 2.7 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.7 | 11.5 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.7 | 2.0 | GO:0042253 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.7 | 2.0 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.6 | 1.3 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.6 | 1.9 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.6 | 4.5 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.6 | 4.5 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.6 | 1.3 | GO:0021564 | vagus nerve development(GO:0021564) |
0.6 | 7.6 | GO:0001553 | luteinization(GO:0001553) |
0.6 | 3.1 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.6 | 2.5 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.6 | 9.7 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.6 | 6.7 | GO:1900746 | regulation of vascular endothelial growth factor signaling pathway(GO:1900746) |
0.6 | 3.6 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
0.6 | 0.6 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
0.6 | 2.4 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.6 | 2.3 | GO:0009115 | xanthine catabolic process(GO:0009115) xanthine metabolic process(GO:0046110) |
0.6 | 0.6 | GO:1903431 | positive regulation of cell maturation(GO:1903431) |
0.6 | 1.7 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.6 | 1.7 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
0.6 | 1.7 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.6 | 1.1 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.6 | 1.7 | GO:0046078 | dUMP metabolic process(GO:0046078) |
0.5 | 1.1 | GO:0014732 | skeletal muscle atrophy(GO:0014732) |
0.5 | 0.5 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.5 | 1.6 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.5 | 1.6 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.5 | 1.0 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
0.5 | 1.6 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
0.5 | 2.6 | GO:2000543 | positive regulation of gastrulation(GO:2000543) |
0.5 | 2.1 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.5 | 8.7 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.5 | 2.0 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.5 | 4.5 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.5 | 2.5 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.5 | 4.4 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.5 | 1.9 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.5 | 29.2 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.5 | 1.0 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.5 | 1.4 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.5 | 0.5 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
0.5 | 0.9 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.5 | 3.7 | GO:0060013 | righting reflex(GO:0060013) |
0.5 | 0.9 | GO:2001258 | negative regulation of cation channel activity(GO:2001258) |
0.5 | 0.9 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.4 | 0.4 | GO:0060594 | mammary gland specification(GO:0060594) |
0.4 | 2.7 | GO:0002667 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
0.4 | 1.3 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.4 | 1.3 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.4 | 1.3 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.4 | 0.9 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.4 | 1.7 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.4 | 2.6 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.4 | 0.4 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.4 | 0.8 | GO:1901977 | negative regulation of cell cycle checkpoint(GO:1901977) |
0.4 | 0.4 | GO:0033058 | directional locomotion(GO:0033058) |
0.4 | 2.9 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.4 | 2.1 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.4 | 1.7 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.4 | 3.3 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.4 | 1.7 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.4 | 1.2 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.4 | 2.5 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.4 | 1.2 | GO:0097195 | pilomotor reflex(GO:0097195) |
0.4 | 0.8 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.4 | 1.2 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.4 | 1.2 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.4 | 1.2 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
0.4 | 2.7 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.4 | 26.2 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.4 | 1.1 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.4 | 2.2 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
0.4 | 6.3 | GO:0046348 | amino sugar catabolic process(GO:0046348) |
0.4 | 1.5 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.4 | 2.6 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.4 | 1.1 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.4 | 4.0 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.4 | 0.7 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
0.4 | 2.5 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
0.4 | 1.1 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.4 | 2.9 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.4 | 6.8 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.4 | 0.7 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.4 | 9.8 | GO:0007617 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.4 | 1.1 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.3 | 5.6 | GO:0001964 | startle response(GO:0001964) |
0.3 | 1.0 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.3 | 0.7 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
0.3 | 3.1 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.3 | 1.4 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.3 | 1.4 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.3 | 3.4 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.3 | 1.0 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.3 | 1.0 | GO:0045915 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.3 | 3.0 | GO:0042428 | serotonin metabolic process(GO:0042428) |
0.3 | 5.3 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.3 | 1.6 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.3 | 3.3 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.3 | 4.5 | GO:0060074 | synapse maturation(GO:0060074) |
0.3 | 1.0 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.3 | 2.2 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.3 | 0.3 | GO:0061743 | motor learning(GO:0061743) |
0.3 | 0.6 | GO:0060174 | limb bud formation(GO:0060174) |
0.3 | 0.9 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.3 | 4.1 | GO:0046541 | saliva secretion(GO:0046541) |
0.3 | 4.3 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.3 | 2.2 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.3 | 0.6 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.3 | 0.3 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.3 | 0.9 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.3 | 0.6 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.3 | 1.5 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.3 | 0.3 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.3 | 0.9 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.3 | 0.6 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
0.3 | 2.7 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.3 | 4.5 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.3 | 1.2 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.3 | 0.9 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
0.3 | 0.6 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.3 | 2.0 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.3 | 0.9 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.3 | 0.3 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
0.3 | 1.4 | GO:0071435 | potassium ion export(GO:0071435) |
0.3 | 2.3 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.3 | 3.7 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.3 | 0.8 | GO:0061511 | centriole elongation(GO:0061511) |
0.3 | 0.6 | GO:0072240 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis(GO:0072309) |
0.3 | 0.3 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.3 | 1.1 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.3 | 1.1 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.3 | 0.8 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.3 | 0.8 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.3 | 0.6 | GO:0060023 | soft palate development(GO:0060023) |
0.3 | 2.5 | GO:0031935 | regulation of chromatin silencing(GO:0031935) |
0.3 | 1.7 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.3 | 1.7 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.3 | 0.6 | GO:2000598 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.3 | 1.4 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.3 | 0.6 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.3 | 0.6 | GO:1900045 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
0.3 | 0.5 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.3 | 0.8 | GO:1904751 | protein localization to nucleolus(GO:1902570) regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
0.3 | 1.9 | GO:0060581 | ventral spinal cord interneuron fate commitment(GO:0060579) cell fate commitment involved in pattern specification(GO:0060581) |
0.3 | 0.5 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.3 | 1.4 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.3 | 5.7 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.3 | 0.3 | GO:0045963 | negative regulation of catecholamine metabolic process(GO:0045914) negative regulation of dopamine metabolic process(GO:0045963) |
0.3 | 0.5 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.3 | 1.5 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.3 | 1.0 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
0.3 | 1.0 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.3 | 1.0 | GO:0051611 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.3 | 1.5 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.3 | 1.8 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
0.3 | 6.0 | GO:0003407 | neural retina development(GO:0003407) |
0.2 | 1.2 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.2 | 0.2 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.2 | 0.7 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.2 | 2.7 | GO:0048302 | regulation of isotype switching to IgG isotypes(GO:0048302) |
0.2 | 0.2 | GO:0061110 | dense core granule biogenesis(GO:0061110) |
0.2 | 1.0 | GO:0030091 | protein repair(GO:0030091) |
0.2 | 1.7 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.2 | 0.7 | GO:0042417 | dopamine metabolic process(GO:0042417) |
0.2 | 4.5 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.2 | 0.5 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.2 | 0.9 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.2 | 1.6 | GO:0001967 | suckling behavior(GO:0001967) |
0.2 | 1.1 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.2 | 0.2 | GO:0015819 | lysine transport(GO:0015819) |
0.2 | 1.8 | GO:0060042 | retina morphogenesis in camera-type eye(GO:0060042) |
0.2 | 0.5 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.2 | 0.5 | GO:0032222 | regulation of synaptic transmission, cholinergic(GO:0032222) positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.2 | 1.3 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.2 | 1.3 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.2 | 0.9 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
0.2 | 0.9 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.2 | 0.7 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.2 | 1.9 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.2 | 0.6 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.2 | 0.4 | GO:0060283 | negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
0.2 | 2.6 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.2 | 0.6 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.2 | 0.6 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.2 | 0.2 | GO:0003211 | cardiac ventricle formation(GO:0003211) |
0.2 | 1.5 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.2 | 1.3 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.2 | 0.2 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
0.2 | 0.6 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.2 | 1.5 | GO:0071501 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.2 | 4.1 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.2 | 0.6 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.2 | 0.4 | GO:2000020 | positive regulation of male gonad development(GO:2000020) |
0.2 | 3.5 | GO:0060441 | epithelial tube branching involved in lung morphogenesis(GO:0060441) |
0.2 | 0.6 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
0.2 | 0.4 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.2 | 0.4 | GO:0021855 | hypothalamus cell migration(GO:0021855) |
0.2 | 1.8 | GO:0060536 | cartilage morphogenesis(GO:0060536) |
0.2 | 1.0 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.2 | 0.2 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
0.2 | 0.8 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.2 | 0.4 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.2 | 1.2 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.2 | 0.2 | GO:0021554 | optic nerve development(GO:0021554) |
0.2 | 0.8 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.2 | 0.6 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
0.2 | 0.6 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.2 | 0.4 | GO:0001927 | exocyst assembly(GO:0001927) |
0.2 | 0.6 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.2 | 0.2 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.2 | 0.6 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.2 | 0.2 | GO:0098700 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.2 | 0.8 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.2 | 7.4 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.2 | 0.6 | GO:0051775 | response to redox state(GO:0051775) |
0.2 | 0.2 | GO:0010909 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.2 | 0.4 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.2 | 0.2 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.2 | 0.2 | GO:0072107 | regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) |
0.2 | 0.9 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.2 | 0.7 | GO:0045343 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
0.2 | 0.5 | GO:1903011 | negative regulation of bone development(GO:1903011) |
0.2 | 0.2 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.2 | 0.4 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.2 | 0.2 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.2 | 0.2 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.2 | 3.0 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
0.2 | 2.7 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.2 | 0.5 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
0.2 | 0.5 | GO:2000553 | positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
0.2 | 0.5 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.2 | 0.5 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.2 | 0.2 | GO:0072198 | mesenchymal cell proliferation involved in ureter development(GO:0072198) regulation of mesenchymal cell proliferation involved in ureter development(GO:0072199) |
0.2 | 0.7 | GO:0045176 | apical protein localization(GO:0045176) |
0.2 | 0.5 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.2 | 1.5 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.2 | 0.2 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.2 | 1.3 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.2 | 0.7 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.2 | 0.5 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.2 | 0.3 | GO:0070253 | somatostatin secretion(GO:0070253) |
0.2 | 0.8 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.2 | 0.2 | GO:0051938 | L-glutamate import(GO:0051938) |
0.2 | 0.5 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.2 | 0.3 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
0.2 | 0.8 | GO:0015808 | L-alanine transport(GO:0015808) |
0.2 | 0.6 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.2 | 0.5 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.2 | 1.1 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.2 | 0.5 | GO:0051126 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) negative regulation of actin nucleation(GO:0051126) |
0.2 | 0.6 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.2 | 0.2 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.2 | 0.9 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.2 | 0.2 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
0.2 | 0.8 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.2 | 0.5 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.2 | 0.5 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.2 | 0.6 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.2 | 0.9 | GO:0006983 | ER overload response(GO:0006983) |
0.1 | 0.3 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.1 | 0.1 | GO:2000412 | thymocyte migration(GO:0072679) regulation of thymocyte migration(GO:2000410) positive regulation of thymocyte migration(GO:2000412) |
0.1 | 0.1 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.1 | 0.1 | GO:0009996 | negative regulation of cell fate specification(GO:0009996) |
0.1 | 1.2 | GO:0060736 | prostate gland growth(GO:0060736) |
0.1 | 0.6 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.1 | 0.1 | GO:0046544 | development of secondary male sexual characteristics(GO:0046544) |
0.1 | 0.6 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.1 | 0.7 | GO:0090042 | tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
0.1 | 0.4 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.1 | 0.3 | GO:0019230 | proprioception(GO:0019230) |
0.1 | 0.4 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.1 | 0.4 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.1 | 0.3 | GO:0002666 | positive regulation of T cell tolerance induction(GO:0002666) |
0.1 | 0.5 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.1 | 0.8 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.1 | 0.4 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.1 | 0.4 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.1 | 0.5 | GO:0007296 | vitellogenesis(GO:0007296) |
0.1 | 0.8 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.1 | 0.3 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.1 | 0.4 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.1 | 0.4 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
0.1 | 0.1 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.1 | 0.4 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.1 | 1.1 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.1 | 0.1 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.1 | 0.4 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.1 | 1.4 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.1 | 0.4 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.1 | 0.5 | GO:0048755 | branching morphogenesis of a nerve(GO:0048755) |
0.1 | 0.4 | GO:1904219 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.1 | 0.1 | GO:0046958 | nonassociative learning(GO:0046958) habituation(GO:0046959) |
0.1 | 0.6 | GO:0042711 | maternal behavior(GO:0042711) |
0.1 | 0.1 | GO:2000850 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.1 | 0.4 | GO:0097503 | sialylation(GO:0097503) |
0.1 | 0.4 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.1 | 2.8 | GO:0031365 | N-terminal protein amino acid modification(GO:0031365) |
0.1 | 0.2 | GO:0008038 | neuron recognition(GO:0008038) |
0.1 | 0.2 | GO:0032429 | regulation of phospholipase A2 activity(GO:0032429) |
0.1 | 0.2 | GO:0036093 | germ cell proliferation(GO:0036093) |
0.1 | 0.6 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.1 | 0.6 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.1 | 0.5 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.1 | 0.7 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
0.1 | 0.2 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.1 | 0.5 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.1 | 0.3 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.1 | 0.1 | GO:0042053 | regulation of dopamine metabolic process(GO:0042053) |
0.1 | 0.3 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.1 | 0.9 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.1 | 0.9 | GO:0097369 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.1 | 0.5 | GO:0072044 | collecting duct development(GO:0072044) |
0.1 | 0.2 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.1 | 0.3 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.1 | 0.7 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.1 | 0.3 | GO:0046504 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
0.1 | 0.1 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.1 | 0.1 | GO:0021538 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
0.1 | 3.0 | GO:0007270 | neuron-neuron synaptic transmission(GO:0007270) |
0.1 | 0.3 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.1 | 0.2 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.1 | 0.3 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 0.2 | GO:0003057 | regulation of the force of heart contraction by chemical signal(GO:0003057) |
0.1 | 0.3 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.1 | 0.8 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 0.2 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.1 | 0.4 | GO:0007207 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.1 | 0.6 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.1 | 0.4 | GO:0032252 | secretory granule localization(GO:0032252) |
0.1 | 1.9 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.1 | 0.7 | GO:0006108 | malate metabolic process(GO:0006108) |
0.1 | 0.4 | GO:0014047 | glutamate secretion(GO:0014047) |
0.1 | 0.4 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.1 | 0.3 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.1 | 0.1 | GO:0060117 | auditory receptor cell development(GO:0060117) |
0.1 | 2.5 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.1 | 0.2 | GO:0038001 | paracrine signaling(GO:0038001) |
0.1 | 0.1 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.1 | 0.3 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.1 | 0.2 | GO:0090383 | phagosome acidification(GO:0090383) |
0.1 | 0.1 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
0.1 | 1.2 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.1 | 1.5 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.1 | 0.3 | GO:0019287 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.1 | 0.2 | GO:0002576 | platelet degranulation(GO:0002576) |
0.1 | 0.1 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.1 | 0.3 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.1 | 0.1 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.1 | 0.7 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.1 | 0.8 | GO:0006760 | folic acid-containing compound metabolic process(GO:0006760) |
0.1 | 0.1 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.1 | 0.2 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.1 | 0.8 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
0.1 | 0.4 | GO:0035627 | ceramide transport(GO:0035627) |
0.1 | 0.3 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.1 | 0.5 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.1 | 0.5 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.1 | 0.5 | GO:0097237 | cellular response to toxic substance(GO:0097237) |
0.1 | 1.5 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
0.1 | 1.4 | GO:1901381 | positive regulation of potassium ion transmembrane transport(GO:1901381) |
0.1 | 0.7 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.1 | 0.5 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.1 | 0.6 | GO:0031000 | response to caffeine(GO:0031000) |
0.1 | 0.3 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.1 | 0.3 | GO:0060452 | positive regulation of cardiac muscle contraction(GO:0060452) |
0.1 | 0.8 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.1 | 0.6 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 0.3 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.1 | 0.5 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.1 | 0.2 | GO:0070662 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) negative regulation of mast cell apoptotic process(GO:0033026) mast cell proliferation(GO:0070662) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
0.1 | 1.3 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.1 | 0.3 | GO:0022615 | protein to membrane docking(GO:0022615) |
0.1 | 0.3 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.1 | 0.4 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.1 | 2.0 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.1 | 0.2 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.1 | 0.3 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.1 | 0.3 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.1 | 2.4 | GO:0045761 | regulation of adenylate cyclase activity(GO:0045761) |
0.1 | 0.3 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.1 | 0.2 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.1 | 0.1 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.1 | 0.7 | GO:0001878 | response to yeast(GO:0001878) |
0.1 | 0.1 | GO:0060676 | ureteric bud formation(GO:0060676) |
0.1 | 0.5 | GO:0000012 | single strand break repair(GO:0000012) |
0.1 | 0.1 | GO:0035826 | rubidium ion transport(GO:0035826) |
0.1 | 0.2 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.1 | 0.2 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.1 | 0.2 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.1 | 0.1 | GO:0061043 | regulation of vascular wound healing(GO:0061043) |
0.1 | 0.4 | GO:0050957 | equilibrioception(GO:0050957) |
0.1 | 0.6 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.1 | 0.2 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.1 | 1.0 | GO:1903963 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.1 | 0.2 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.1 | 0.2 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.1 | 0.3 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.1 | 0.6 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.1 | 0.4 | GO:0001845 | phagolysosome assembly(GO:0001845) |
0.1 | 0.2 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.1 | 0.2 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.1 | 0.1 | GO:0071899 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
0.1 | 0.2 | GO:0045991 | carbon catabolite activation of transcription(GO:0045991) |
0.1 | 0.1 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.1 | 0.5 | GO:0045605 | negative regulation of epidermal cell differentiation(GO:0045605) negative regulation of keratinocyte differentiation(GO:0045617) |
0.1 | 0.2 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.1 | 0.1 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.1 | 0.1 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.1 | 0.8 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 0.1 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.1 | 0.1 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
0.1 | 0.3 | GO:1900113 | regulation of histone H3-K9 trimethylation(GO:1900112) negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.1 | 0.2 | GO:0009211 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate metabolic process(GO:0009211) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.1 | 0.2 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.1 | 0.6 | GO:0006273 | lagging strand elongation(GO:0006273) |
0.1 | 0.1 | GO:0002434 | immune complex clearance(GO:0002434) |
0.1 | 0.2 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.1 | 0.2 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.1 | 0.1 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
0.1 | 0.1 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
0.1 | 0.1 | GO:1903121 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.1 | 0.3 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.1 | 0.1 | GO:0055009 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.1 | 0.1 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.1 | 0.5 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.1 | 0.7 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.1 | 0.2 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.1 | 0.3 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.1 | 0.3 | GO:1903894 | regulation of IRE1-mediated unfolded protein response(GO:1903894) |
0.1 | 0.8 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.1 | 0.1 | GO:0009080 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
0.1 | 0.3 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.1 | 0.3 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.1 | 0.2 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.1 | 0.4 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.1 | 0.3 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.1 | 0.2 | GO:0032907 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) |
0.1 | 0.6 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.1 | 0.3 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 0.1 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.1 | 0.1 | GO:0010288 | response to lead ion(GO:0010288) |
0.1 | 0.5 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.1 | 0.3 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.1 | 0.1 | GO:0045759 | negative regulation of action potential(GO:0045759) |
0.1 | 0.8 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.1 | 0.2 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
0.1 | 0.2 | GO:1903358 | regulation of Golgi organization(GO:1903358) |
0.1 | 0.1 | GO:0033084 | regulation of immature T cell proliferation in thymus(GO:0033084) |
0.1 | 0.3 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
0.1 | 0.3 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.1 | 0.5 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.1 | 0.3 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.1 | 0.2 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.1 | 0.2 | GO:0051697 | protein delipidation(GO:0051697) |
0.1 | 0.6 | GO:0032119 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.1 | 0.1 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
0.1 | 0.2 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.1 | 0.1 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.1 | 0.6 | GO:0080111 | DNA demethylation(GO:0080111) |
0.1 | 2.8 | GO:0007612 | learning(GO:0007612) |
0.1 | 0.2 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.1 | 0.1 | GO:1903298 | regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) |
0.1 | 0.4 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.1 | 0.4 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.1 | 0.1 | GO:0033091 | positive regulation of immature T cell proliferation(GO:0033091) |
0.1 | 0.2 | GO:0015747 | urate transport(GO:0015747) |
0.1 | 0.1 | GO:0003174 | mitral valve development(GO:0003174) |
0.1 | 0.2 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.1 | 0.2 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.1 | 0.1 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.1 | 0.1 | GO:0034756 | regulation of iron ion transport(GO:0034756) |
0.1 | 0.1 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.1 | 0.1 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 0.4 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.1 | 0.2 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.1 | 0.2 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.1 | 0.2 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.1 | 0.1 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.1 | 0.1 | GO:0060157 | urinary bladder development(GO:0060157) |
0.1 | 0.1 | GO:0035425 | autocrine signaling(GO:0035425) |
0.1 | 0.5 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.1 | 0.1 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.1 | 0.4 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.1 | 0.2 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.1 | 0.3 | GO:1990845 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.1 | 0.5 | GO:0045056 | transcytosis(GO:0045056) |
0.1 | 0.1 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.1 | 0.3 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.0 | 0.0 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
0.0 | 0.1 | GO:0048069 | eye pigmentation(GO:0048069) |
0.0 | 0.1 | GO:0021854 | hypothalamus development(GO:0021854) |
0.0 | 0.0 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.0 | 0.2 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
0.0 | 0.1 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.0 | 0.0 | GO:1904139 | microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
0.0 | 0.1 | GO:0061055 | myotome development(GO:0061055) |
0.0 | 0.2 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.0 | 0.0 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.0 | 0.2 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
0.0 | 0.2 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.0 | 0.0 | GO:0033083 | regulation of immature T cell proliferation(GO:0033083) |
0.0 | 0.2 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.0 | 0.1 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.0 | 0.4 | GO:0042407 | cristae formation(GO:0042407) |
0.0 | 0.2 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.0 | 0.1 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
0.0 | 0.0 | GO:1902488 | cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
0.0 | 0.1 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.0 | 0.2 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.0 | 0.0 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
0.0 | 0.1 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.0 | 0.4 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.0 | 0.1 | GO:0061687 | detoxification of inorganic compound(GO:0061687) |
0.0 | 0.1 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.0 | 0.1 | GO:0048102 | autophagic cell death(GO:0048102) |
0.0 | 0.0 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.0 | 0.3 | GO:0051705 | multi-organism behavior(GO:0051705) |
0.0 | 0.8 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.0 | 0.1 | GO:0043576 | regulation of respiratory gaseous exchange(GO:0043576) |
0.0 | 0.2 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.0 | 0.0 | GO:0060746 | parental behavior(GO:0060746) |
0.0 | 0.0 | GO:0008354 | germ cell migration(GO:0008354) |
0.0 | 0.1 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.0 | 0.1 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.0 | 0.1 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.0 | 0.0 | GO:1902075 | cellular response to salt(GO:1902075) |
0.0 | 0.1 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.0 | 0.1 | GO:0002517 | T cell tolerance induction(GO:0002517) |
0.0 | 0.1 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.0 | 0.0 | GO:0072017 | distal tubule development(GO:0072017) |
0.0 | 0.0 | GO:1901160 | primary amino compound metabolic process(GO:1901160) |
0.0 | 0.4 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.0 | 0.0 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) |
0.0 | 0.2 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.0 | 0.1 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
0.0 | 0.1 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.0 | 0.3 | GO:1900118 | negative regulation of execution phase of apoptosis(GO:1900118) |
0.0 | 0.1 | GO:0051138 | regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.0 | 0.0 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
0.0 | 0.3 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.0 | 0.0 | GO:2001212 | regulation of vasculogenesis(GO:2001212) |
0.0 | 0.1 | GO:0030242 | pexophagy(GO:0030242) |
0.0 | 0.1 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.0 | 0.1 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.0 | 0.1 | GO:0048023 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.0 | 0.8 | GO:0034605 | cellular response to heat(GO:0034605) |
0.0 | 0.3 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.0 | 0.0 | GO:0006522 | alanine metabolic process(GO:0006522) pyruvate family amino acid metabolic process(GO:0009078) L-alanine metabolic process(GO:0042851) |
0.0 | 0.1 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.0 | 0.0 | GO:0072553 | terminal button organization(GO:0072553) |
0.0 | 0.1 | GO:0034727 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) |
0.0 | 0.0 | GO:1902262 | apoptotic process involved in patterning of blood vessels(GO:1902262) |
0.0 | 2.3 | GO:0007605 | sensory perception of sound(GO:0007605) |
0.0 | 0.0 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.0 | 0.1 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.0 | 0.1 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.0 | 0.1 | GO:0006562 | proline catabolic process(GO:0006562) |
0.0 | 0.1 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.0 | 0.1 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.0 | 0.2 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.0 | GO:0090135 | actin filament branching(GO:0090135) |
0.0 | 0.0 | GO:0014889 | muscle atrophy(GO:0014889) |
0.0 | 0.2 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
0.0 | 0.1 | GO:0023019 | signal transduction involved in regulation of gene expression(GO:0023019) |
0.0 | 0.1 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.0 | 0.1 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
0.0 | 0.1 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.0 | 0.1 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.0 | 0.1 | GO:0031034 | myosin filament assembly(GO:0031034) |
0.0 | 0.1 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.0 | 0.0 | GO:0045354 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
0.0 | 0.1 | GO:1902572 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.0 | 0.1 | GO:2000561 | regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.0 | 0.0 | GO:0018377 | protein myristoylation(GO:0018377) |
0.0 | 0.1 | GO:1901026 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.0 | 0.1 | GO:0019249 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.0 | 0.0 | GO:0046490 | isopentenyl diphosphate metabolic process(GO:0046490) |
0.0 | 0.3 | GO:0048663 | neuron fate commitment(GO:0048663) |
0.0 | 0.0 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
0.0 | 1.1 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 0.2 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.0 | 0.2 | GO:0003334 | keratinocyte development(GO:0003334) |
0.0 | 0.1 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.0 | 0.1 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.0 | 0.2 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.0 | 0.1 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.0 | 0.1 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.0 | 0.0 | GO:0045869 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.0 | 0.2 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.0 | 0.1 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.0 | 0.1 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.0 | 0.0 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
0.0 | 0.1 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.0 | 0.1 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.0 | 0.0 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.0 | 0.0 | GO:0019064 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.0 | 0.1 | GO:0002857 | positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
0.0 | 0.0 | GO:0072126 | positive regulation of glomerular mesangial cell proliferation(GO:0072126) |
0.0 | 0.1 | GO:0051639 | actin filament network formation(GO:0051639) |
0.0 | 0.0 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.0 | 0.0 | GO:0090330 | regulation of platelet aggregation(GO:0090330) |
0.0 | 0.0 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.0 | 0.0 | GO:0031049 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.0 | 0.1 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.0 | 0.1 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.0 | 0.0 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.0 | 0.1 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.0 | 0.6 | GO:0035914 | skeletal muscle cell differentiation(GO:0035914) |
0.0 | 0.0 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.0 | 0.1 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.0 | 0.0 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
0.0 | 0.3 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.0 | 0.0 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.0 | 0.0 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.0 | 0.0 | GO:0070723 | response to cholesterol(GO:0070723) |
0.0 | 0.0 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.0 | 0.0 | GO:2000551 | regulation of T-helper 2 cell cytokine production(GO:2000551) |
0.0 | 0.0 | GO:0098828 | modulation of inhibitory postsynaptic potential(GO:0098828) |
0.0 | 0.2 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.0 | 0.1 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.0 | 0.1 | GO:0006265 | DNA topological change(GO:0006265) |
0.0 | 0.0 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
0.0 | 0.1 | GO:0007628 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.0 | 0.0 | GO:1902065 | response to L-glutamate(GO:1902065) |
0.0 | 0.2 | GO:0042095 | interferon-gamma biosynthetic process(GO:0042095) |
0.0 | 0.0 | GO:0035747 | natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) |
0.0 | 0.1 | GO:0071569 | protein ufmylation(GO:0071569) protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.0 | 0.0 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.0 | 0.1 | GO:0021799 | cerebral cortex radially oriented cell migration(GO:0021799) |
0.0 | 0.0 | GO:0061010 | gall bladder development(GO:0061010) |
0.0 | 0.1 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.0 | 0.2 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.0 | 0.0 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.0 | 0.0 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.0 | 0.1 | GO:0051926 | negative regulation of calcium ion transport(GO:0051926) |
0.0 | 0.1 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.2 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.0 | 0.1 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 0.0 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
0.0 | 0.0 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) |
0.0 | 0.1 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.0 | 0.0 | GO:0006311 | meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
0.0 | 0.0 | GO:1903430 | negative regulation of cell maturation(GO:1903430) |
0.0 | 0.0 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
0.0 | 0.1 | GO:0060359 | response to ammonium ion(GO:0060359) |
0.0 | 0.0 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
0.0 | 0.0 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.0 | 0.0 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.0 | 0.0 | GO:0035973 | aggrephagy(GO:0035973) |
0.0 | 0.0 | GO:0009624 | response to nematode(GO:0009624) |
0.0 | 0.0 | GO:0032439 | endosome localization(GO:0032439) |
0.0 | 0.0 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) |
0.0 | 0.0 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.0 | 0.1 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.0 | 0.0 | GO:0042363 | vitamin catabolic process(GO:0009111) fat-soluble vitamin catabolic process(GO:0042363) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 8.0 | GO:0043194 | axon initial segment(GO:0043194) |
1.8 | 5.4 | GO:0000814 | ESCRT II complex(GO:0000814) |
1.8 | 12.6 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
1.3 | 13.3 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
1.2 | 3.7 | GO:0070552 | BRISC complex(GO:0070552) |
1.2 | 9.4 | GO:0043083 | synaptic cleft(GO:0043083) |
1.2 | 5.8 | GO:0097433 | dense body(GO:0097433) |
1.1 | 3.4 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
1.1 | 5.3 | GO:0044294 | dendritic growth cone(GO:0044294) |
1.0 | 3.9 | GO:0033010 | paranodal junction(GO:0033010) |
1.0 | 6.8 | GO:0016342 | catenin complex(GO:0016342) |
1.0 | 7.6 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.9 | 2.8 | GO:0097441 | basilar dendrite(GO:0097441) |
0.9 | 7.8 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.8 | 2.5 | GO:0048179 | activin receptor complex(GO:0048179) |
0.8 | 2.4 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.8 | 3.9 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.8 | 3.0 | GO:0044308 | axonal spine(GO:0044308) |
0.7 | 4.4 | GO:0032584 | growth cone membrane(GO:0032584) |
0.7 | 2.2 | GO:0016939 | kinesin II complex(GO:0016939) |
0.6 | 1.9 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.6 | 0.6 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.6 | 7.4 | GO:0033268 | node of Ranvier(GO:0033268) |
0.6 | 4.2 | GO:0071437 | invadopodium(GO:0071437) |
0.6 | 12.5 | GO:0044295 | axonal growth cone(GO:0044295) |
0.6 | 9.8 | GO:0030673 | axolemma(GO:0030673) |
0.6 | 2.3 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.5 | 3.1 | GO:0016011 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.5 | 4.1 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.5 | 0.5 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.5 | 21.9 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.5 | 7.2 | GO:0031527 | filopodium membrane(GO:0031527) |
0.5 | 1.9 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.4 | 1.3 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.4 | 0.4 | GO:0072588 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
0.4 | 1.2 | GO:0042585 | germinal vesicle(GO:0042585) |
0.4 | 68.5 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.3 | 11.3 | GO:0043198 | dendritic shaft(GO:0043198) |
0.3 | 4.8 | GO:0043196 | varicosity(GO:0043196) |
0.3 | 3.3 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.3 | 3.9 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.3 | 5.0 | GO:0005614 | interstitial matrix(GO:0005614) |
0.3 | 0.9 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.3 | 1.2 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.3 | 9.4 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.3 | 1.6 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.3 | 0.8 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.3 | 2.9 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.3 | 1.3 | GO:0005915 | zonula adherens(GO:0005915) |
0.3 | 0.8 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.2 | 3.2 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.2 | 1.2 | GO:0000346 | transcription export complex(GO:0000346) |
0.2 | 0.7 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.2 | 2.8 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.2 | 0.7 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.2 | 2.1 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.2 | 1.5 | GO:0033263 | CORVET complex(GO:0033263) |
0.2 | 2.5 | GO:0033646 | host cell cytoplasm(GO:0030430) host intracellular part(GO:0033646) host cell cytoplasm part(GO:0033655) intracellular region of host(GO:0043656) |
0.2 | 2.5 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.2 | 1.0 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.2 | 0.8 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.2 | 4.2 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.2 | 1.4 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.2 | 0.8 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.2 | 0.8 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.2 | 2.2 | GO:0097060 | synaptic membrane(GO:0097060) |
0.2 | 1.8 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.2 | 0.2 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.2 | 1.7 | GO:0097542 | ciliary tip(GO:0097542) |
0.2 | 0.8 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.2 | 20.7 | GO:0060076 | excitatory synapse(GO:0060076) |
0.2 | 0.9 | GO:0000796 | condensin complex(GO:0000796) |
0.2 | 1.3 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.2 | 0.5 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.2 | 1.7 | GO:0032426 | stereocilium tip(GO:0032426) |
0.2 | 1.2 | GO:0033270 | paranode region of axon(GO:0033270) |
0.2 | 1.4 | GO:0034464 | BBSome(GO:0034464) |
0.2 | 0.3 | GO:0072534 | perineuronal net(GO:0072534) |
0.2 | 0.5 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.2 | 1.7 | GO:0035102 | PRC1 complex(GO:0035102) |
0.1 | 1.4 | GO:0031045 | dense core granule(GO:0031045) |
0.1 | 0.5 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.1 | 1.3 | GO:0046930 | pore complex(GO:0046930) |
0.1 | 13.4 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.1 | 5.9 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.1 | 0.4 | GO:0005955 | calcineurin complex(GO:0005955) |
0.1 | 0.5 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 0.9 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 0.4 | GO:0097422 | tubular endosome(GO:0097422) |
0.1 | 0.3 | GO:0000802 | transverse filament(GO:0000802) |
0.1 | 0.3 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.1 | 0.3 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 0.3 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 1.2 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 0.4 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.1 | 0.6 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.1 | 0.4 | GO:0097452 | GAIT complex(GO:0097452) |
0.1 | 0.5 | GO:0061617 | MICOS complex(GO:0061617) |
0.1 | 0.5 | GO:0002177 | manchette(GO:0002177) |
0.1 | 1.4 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 0.9 | GO:0032797 | SMN complex(GO:0032797) |
0.1 | 0.3 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.1 | 0.5 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 0.1 | GO:0032010 | phagolysosome(GO:0032010) |
0.1 | 1.0 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.1 | 0.1 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.1 | 0.5 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.1 | 0.6 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.1 | 2.9 | GO:0005747 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.1 | 0.1 | GO:0033269 | internode region of axon(GO:0033269) |
0.1 | 0.2 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.1 | 0.2 | GO:0030689 | Noc complex(GO:0030689) |
0.1 | 1.4 | GO:0034451 | centriolar satellite(GO:0034451) |
0.1 | 0.3 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.1 | 0.2 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.1 | 0.3 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.1 | 0.6 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
0.1 | 0.2 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 1.4 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 0.4 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.1 | 2.8 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 0.7 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.1 | 0.4 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 0.2 | GO:0097342 | ripoptosome(GO:0097342) |
0.1 | 0.3 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.1 | 0.2 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.0 | 0.1 | GO:0035061 | interchromatin granule(GO:0035061) |
0.0 | 0.1 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.0 | 0.9 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 0.1 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.0 | 0.2 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.0 | 0.2 | GO:0070545 | PeBoW complex(GO:0070545) |
0.0 | 6.0 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.0 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.0 | 0.1 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.0 | 0.1 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.0 | 0.2 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.0 | 0.3 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.0 | 0.2 | GO:0070852 | cell body fiber(GO:0070852) |
0.0 | 0.4 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 0.1 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.0 | 0.6 | GO:0030914 | STAGA complex(GO:0030914) |
0.0 | 0.1 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.0 | 2.3 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.1 | GO:0044299 | C-fiber(GO:0044299) |
0.0 | 0.1 | GO:0043293 | apoptosome(GO:0043293) |
0.0 | 0.3 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.0 | 0.1 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.0 | 0.3 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.0 | 2.0 | GO:0030427 | site of polarized growth(GO:0030427) |
0.0 | 3.3 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.0 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.0 | 0.3 | GO:0036156 | inner dynein arm(GO:0036156) |
0.0 | 0.0 | GO:0000125 | PCAF complex(GO:0000125) |
0.0 | 0.1 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.0 | 0.1 | GO:0071953 | elastic fiber(GO:0071953) |
0.0 | 0.0 | GO:0043219 | lateral loop(GO:0043219) |
0.0 | 0.1 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.0 | 0.4 | GO:0070822 | Sin3-type complex(GO:0070822) |
0.0 | 0.0 | GO:1990923 | PET complex(GO:1990923) |
0.0 | 0.1 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.0 | 0.0 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.0 | 0.3 | GO:0033391 | chromatoid body(GO:0033391) |
0.0 | 0.1 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.0 | 0.0 | GO:0030897 | HOPS complex(GO:0030897) |
0.0 | 0.0 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.0 | 0.2 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 0.1 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.0 | 0.5 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.0 | 0.1 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.0 | 0.0 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.0 | 0.1 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.0 | 0.1 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.0 | 0.1 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.0 | 0.1 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.0 | 0.1 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.0 | 0.0 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.0 | 0.1 | GO:0001940 | male pronucleus(GO:0001940) |
0.0 | 0.0 | GO:0071942 | XPC complex(GO:0071942) |
0.0 | 0.5 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.3 | 9.8 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
3.0 | 9.1 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
3.0 | 12.0 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
2.1 | 6.4 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
2.1 | 12.7 | GO:0004385 | guanylate kinase activity(GO:0004385) |
1.9 | 1.9 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
1.8 | 5.4 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
1.7 | 8.6 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
1.5 | 4.6 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
1.5 | 4.5 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
1.5 | 13.6 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
1.5 | 7.4 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
1.4 | 11.5 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
1.4 | 4.1 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
1.3 | 6.5 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
1.2 | 4.9 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
1.2 | 2.5 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
1.2 | 3.7 | GO:0050816 | phosphothreonine binding(GO:0050816) |
1.2 | 4.9 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
1.1 | 1.1 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
1.1 | 3.2 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
1.1 | 3.2 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.9 | 1.8 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.9 | 3.5 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.9 | 7.8 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.9 | 2.6 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.8 | 2.5 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.8 | 0.8 | GO:0016937 | short-branched-chain-acyl-CoA dehydrogenase activity(GO:0016937) |
0.8 | 3.3 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.8 | 7.2 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.7 | 2.2 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.7 | 2.2 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.7 | 2.0 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.6 | 1.9 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.6 | 2.5 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.6 | 4.9 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.6 | 4.3 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
0.6 | 1.8 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.6 | 3.0 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.6 | 4.1 | GO:0043495 | protein anchor(GO:0043495) |
0.6 | 8.1 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.6 | 2.9 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.6 | 2.2 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.6 | 1.7 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.6 | 1.7 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.5 | 3.8 | GO:0003680 | AT DNA binding(GO:0003680) |
0.5 | 0.5 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
0.5 | 1.6 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.5 | 3.2 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.5 | 1.0 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.5 | 2.5 | GO:0004031 | aldehyde oxidase activity(GO:0004031) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.5 | 2.5 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.5 | 1.4 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.5 | 8.3 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
0.4 | 4.9 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.4 | 3.1 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.4 | 1.3 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.4 | 0.4 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.4 | 16.3 | GO:0019894 | kinesin binding(GO:0019894) |
0.4 | 1.3 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.4 | 1.2 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.4 | 4.5 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.4 | 1.2 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.4 | 4.5 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.4 | 2.2 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.4 | 2.2 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.4 | 1.8 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.4 | 1.5 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.4 | 1.1 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.4 | 3.9 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.3 | 1.3 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.3 | 1.7 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.3 | 1.0 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.3 | 1.0 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.3 | 7.3 | GO:0004118 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.3 | 1.0 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.3 | 7.5 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.3 | 1.6 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.3 | 6.5 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.3 | 5.7 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.3 | 1.2 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.3 | 5.3 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.3 | 3.4 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.3 | 1.5 | GO:1990254 | keratin filament binding(GO:1990254) |
0.3 | 0.6 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.3 | 10.7 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.3 | 1.5 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.3 | 0.9 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.3 | 2.3 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.3 | 0.8 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.3 | 4.2 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.3 | 0.6 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.3 | 3.0 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.3 | 0.8 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.3 | 1.1 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.3 | 0.8 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.3 | 1.3 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.3 | 0.5 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.3 | 1.0 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.3 | 1.3 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.3 | 0.8 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.3 | 3.3 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.3 | 1.3 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.2 | 0.5 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.2 | 1.0 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.2 | 1.0 | GO:0070052 | collagen V binding(GO:0070052) |
0.2 | 0.9 | GO:0043723 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
0.2 | 4.1 | GO:0005112 | Notch binding(GO:0005112) |
0.2 | 5.0 | GO:0045296 | cadherin binding(GO:0045296) |
0.2 | 0.9 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.2 | 1.1 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.2 | 0.2 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.2 | 0.9 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.2 | 1.5 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.2 | 0.6 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.2 | 2.1 | GO:0004568 | chitinase activity(GO:0004568) |
0.2 | 4.5 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.2 | 0.8 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.2 | 0.2 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.2 | 0.8 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.2 | 3.9 | GO:0030332 | cyclin binding(GO:0030332) |
0.2 | 0.8 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.2 | 1.5 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.2 | 0.6 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.2 | 2.7 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.2 | 0.6 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.2 | 0.6 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.2 | 4.1 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.2 | 0.9 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.2 | 2.0 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.2 | 3.4 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.2 | 0.5 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.2 | 5.0 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.2 | 3.8 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
0.2 | 0.9 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.2 | 0.2 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.2 | 3.1 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.2 | 0.3 | GO:0022824 | transmitter-gated ion channel activity(GO:0022824) transmitter-gated channel activity(GO:0022835) |
0.2 | 3.2 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.2 | 0.5 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.2 | 0.6 | GO:0031433 | telethonin binding(GO:0031433) |
0.2 | 1.1 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.2 | 0.8 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.2 | 1.4 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.2 | 1.4 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.2 | 3.0 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.2 | 0.6 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.2 | 0.6 | GO:0045545 | syndecan binding(GO:0045545) |
0.2 | 3.5 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.2 | 0.8 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.2 | 0.6 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.2 | 0.8 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.1 | 2.8 | GO:0031489 | myosin V binding(GO:0031489) |
0.1 | 1.6 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 0.6 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.1 | 2.2 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 2.0 | GO:0016917 | GABA receptor activity(GO:0016917) |
0.1 | 1.6 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
0.1 | 1.1 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.1 | 1.5 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 4.0 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 0.1 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
0.1 | 1.3 | GO:0015386 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.1 | 0.4 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.1 | 1.2 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 0.1 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.1 | 1.5 | GO:0043733 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
0.1 | 3.3 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 0.2 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.1 | 0.7 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.1 | 0.5 | GO:0097001 | ceramide binding(GO:0097001) |
0.1 | 0.7 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.1 | 0.1 | GO:0032357 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.1 | 0.5 | GO:0034604 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.1 | 0.8 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.1 | 0.7 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.1 | 2.6 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.1 | 1.2 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.1 | 0.8 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.1 | 0.1 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.1 | 0.2 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.1 | 0.1 | GO:0004337 | geranyltranstransferase activity(GO:0004337) |
0.1 | 2.2 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 0.4 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.1 | 2.0 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.1 | 1.0 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 0.3 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.1 | 0.2 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.1 | 0.5 | GO:0030553 | cGMP binding(GO:0030553) |
0.1 | 0.3 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.1 | 0.3 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.1 | 0.4 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.1 | 1.4 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 0.9 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.1 | 1.0 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.1 | 0.5 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.1 | 1.3 | GO:0032183 | SUMO binding(GO:0032183) |
0.1 | 2.1 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.1 | 0.6 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.1 | 0.4 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.1 | 0.4 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.1 | 0.1 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.1 | 0.4 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.1 | 0.4 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.1 | 0.3 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.1 | 1.0 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.1 | 0.7 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.1 | 0.8 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.4 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.1 | 0.9 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.1 | 0.2 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.1 | 0.6 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.1 | 0.2 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.1 | 0.2 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.1 | 0.3 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.1 | 0.3 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.1 | 0.2 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.1 | 0.1 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.1 | 1.3 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.1 | 1.2 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.1 | 0.3 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.1 | 0.2 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.1 | 0.1 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.1 | 0.7 | GO:0008932 | lytic endotransglycosylase activity(GO:0008932) |
0.1 | 0.1 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.1 | 1.1 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.1 | 0.2 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.1 | 0.1 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.1 | 0.5 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.1 | 0.3 | GO:0017040 | ceramidase activity(GO:0017040) |
0.1 | 0.2 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.1 | 0.2 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.1 | 0.1 | GO:0032190 | acrosin binding(GO:0032190) |
0.1 | 0.3 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.1 | 0.2 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.1 | 0.7 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 0.3 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.1 | 0.4 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 0.2 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.1 | 0.1 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.1 | 0.4 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.1 | 0.2 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.1 | 0.2 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.1 | 0.5 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.1 | 0.2 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.1 | 0.2 | GO:0030547 | receptor inhibitor activity(GO:0030547) |
0.1 | 0.1 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.1 | 0.1 | GO:0086056 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.1 | 0.2 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.1 | 0.2 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.1 | 0.1 | GO:0030519 | snoRNP binding(GO:0030519) |
0.0 | 0.4 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.0 | 0.4 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.0 | 0.1 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.0 | 0.2 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.0 | 0.8 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.0 | 0.2 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.0 | 0.3 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.0 | 0.1 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
0.0 | 0.0 | GO:0035939 | microsatellite binding(GO:0035939) |
0.0 | 0.3 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.0 | 3.4 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.0 | 0.1 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.0 | 0.8 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.0 | 0.1 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.0 | 0.5 | GO:0015026 | coreceptor activity(GO:0015026) |
0.0 | 0.2 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.0 | 0.2 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.0 | 0.2 | GO:0052795 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.0 | 0.1 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.0 | 0.1 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.0 | 0.7 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.0 | 0.2 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.0 | 0.2 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.0 | 0.1 | GO:0048495 | Roundabout binding(GO:0048495) |
0.0 | 0.8 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.1 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.0 | 1.1 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.0 | 0.3 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.0 | 0.5 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.0 | 0.2 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.0 | 0.0 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.0 | 0.1 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.0 | 0.1 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.0 | 0.2 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.0 | 0.2 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.0 | 0.1 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.0 | 0.1 | GO:0004096 | catalase activity(GO:0004096) |
0.0 | 1.0 | GO:0016232 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) heparan sulfate 2-O-sulfotransferase activity(GO:0004394) HNK-1 sulfotransferase activity(GO:0016232) heparan sulfate 6-O-sulfotransferase activity(GO:0017095) trans-9R,10R-dihydrodiolphenanthrene sulfotransferase activity(GO:0018721) 1-phenanthrol sulfotransferase activity(GO:0018722) 3-phenanthrol sulfotransferase activity(GO:0018723) 4-phenanthrol sulfotransferase activity(GO:0018724) trans-3,4-dihydrodiolphenanthrene sulfotransferase activity(GO:0018725) 9-phenanthrol sulfotransferase activity(GO:0018726) 2-phenanthrol sulfotransferase activity(GO:0018727) phenanthrol sulfotransferase activity(GO:0019111) 1-hydroxypyrene sulfotransferase activity(GO:0034930) proteoglycan sulfotransferase activity(GO:0050698) cholesterol sulfotransferase activity(GO:0051922) hydroxyjasmonate sulfotransferase activity(GO:0080131) |
0.0 | 0.3 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.0 | 0.1 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.0 | 1.0 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.0 | 0.3 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.0 | 0.1 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.0 | 0.2 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.0 | 0.1 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.0 | 0.1 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.0 | 0.1 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 0.1 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.0 | 0.0 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.0 | 0.2 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.0 | 0.1 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.0 | 0.0 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.0 | 0.1 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.0 | 0.0 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.0 | 0.1 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.0 | 0.2 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.1 | GO:0030552 | cAMP binding(GO:0030552) |
0.0 | 0.0 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.0 | 0.1 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.0 | 0.1 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.0 | 0.0 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.0 | 0.0 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.0 | 0.0 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.0 | 0.5 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 0.1 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
0.0 | 0.0 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.0 | 0.1 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.0 | 0.1 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.0 | 0.1 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.0 | 0.0 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.0 | 0.0 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
0.0 | 0.0 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.0 | 0.0 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.1 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.0 | 0.1 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.0 | 0.1 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.0 | 0.0 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 1.6 | PID REELIN PATHWAY | Reelin signaling pathway |
0.6 | 16.7 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.4 | 4.2 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.4 | 12.5 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.4 | 7.0 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.3 | 4.4 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.3 | 10.8 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.2 | 1.7 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.2 | 4.4 | PID MYC PATHWAY | C-MYC pathway |
0.2 | 17.3 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.2 | 2.6 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.2 | 8.1 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.2 | 2.8 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.2 | 0.3 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.2 | 1.6 | PID ATR PATHWAY | ATR signaling pathway |
0.2 | 4.3 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.2 | 0.5 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.1 | 0.4 | PID IGF1 PATHWAY | IGF1 pathway |
0.1 | 1.0 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 1.6 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.1 | 3.5 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 0.3 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 0.5 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.1 | 0.6 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.1 | 3.6 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.1 | 1.1 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 0.5 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 1.8 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 1.0 | PID ENDOTHELIN PATHWAY | Endothelins |
0.1 | 2.1 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 0.9 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 0.4 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 0.6 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 0.4 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 0.6 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 0.1 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 0.1 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.6 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 1.1 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 0.3 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 0.4 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.0 | 0.9 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.3 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 0.1 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.2 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.0 | 0.1 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.0 | ST STAT3 PATHWAY | STAT3 Pathway |
0.0 | 0.5 | PID NOTCH PATHWAY | Notch signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 23.2 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.7 | 8.4 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.5 | 4.2 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.5 | 1.0 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.5 | 7.1 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.5 | 5.3 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.4 | 5.8 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.4 | 0.9 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.4 | 7.0 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.4 | 2.6 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.4 | 4.1 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.3 | 4.7 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.3 | 2.3 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.3 | 0.6 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.3 | 9.2 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.3 | 5.7 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.3 | 12.7 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.3 | 1.4 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.3 | 2.6 | REACTOME GABA RECEPTOR ACTIVATION | Genes involved in GABA receptor activation |
0.3 | 3.6 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.3 | 6.4 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.2 | 6.2 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.2 | 4.3 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.2 | 0.9 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.2 | 5.9 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.2 | 3.5 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.2 | 0.8 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.2 | 1.4 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.2 | 2.4 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.2 | 1.8 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.2 | 0.4 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.2 | 4.3 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.2 | 1.3 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.2 | 0.2 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.2 | 3.3 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.2 | 2.3 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.2 | 2.1 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.2 | 0.3 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.2 | 1.5 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.2 | 0.3 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
0.2 | 0.3 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.1 | 3.2 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 3.1 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.1 | 0.1 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.1 | 1.2 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 1.0 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.1 | 1.3 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 1.3 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 2.1 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 1.3 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.1 | 0.2 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.1 | 3.5 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.1 | 1.3 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.1 | 0.1 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.1 | 1.8 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.1 | 1.4 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 1.2 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
0.1 | 0.6 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.1 | 0.8 | REACTOME DEVELOPMENTAL BIOLOGY | Genes involved in Developmental Biology |
0.1 | 0.6 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.1 | 0.5 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.1 | 1.0 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.1 | 1.1 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.1 | 2.7 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.1 | 5.0 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.1 | 0.7 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 1.4 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.1 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.1 | 0.1 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.1 | 2.8 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
0.1 | 0.9 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.1 | 0.1 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.1 | 1.8 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 0.4 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.1 | 0.1 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.1 | 0.1 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
0.0 | 0.8 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 0.9 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.0 | 0.1 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.0 | 0.2 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.0 | 0.4 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.2 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.0 | 0.3 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.0 | 0.1 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.0 | 0.2 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.0 | 0.2 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.0 | 0.3 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.0 | 0.2 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.6 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.0 | 0.3 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 0.1 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 0.1 | REACTOME FGFR LIGAND BINDING AND ACTIVATION | Genes involved in FGFR ligand binding and activation |
0.0 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.0 | 0.2 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.0 | 0.1 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |